Skip to main content
Log in

Effectiveness of Low Dose of Gonadotropin Releasing Hormone Agonist on Hormonal Flare-Up

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose: The hormonal response (flare-up) followingadministration of a standard dose (100 μg) or a low dose(25 μg) of gonadotropin releasing hormone agonist(GnRH-a) (Triptorelin) was compared in patients prior to an in vitrofertilization (IVF) cycle and during the early follicular phaseof a short-term IVF protocol.

Methods: The gonadotroph (FSH, LH) and steroid [estradiol(E2) and progesterone (P)] flare-up was studied on twoconsecutive cycles in 30 normo-ovulatory women. Patientswere randomized to receive either 25 or 100 μg of triptorelinfor three days at the beginning of the first cycle. Then doseswere switched according to a crossing over design in thesecond cycle.

Results: No significant difference in the magnitude of FSHand E2 release could be observed following administrationof the two doses of agonist whereas maximal plasma LHlevel was significantly reduced after injection of 25 μg oftriptorelin.

Conclusions: As compared to a standard dose, using a lowdose of GnRH-a induces an hormonal flare-up which seemsadequate for an optimal follicular recruitment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Hughes EG, Sagle MA, Federkow DM, Van de Koppel P, Daya S, Collins JA: The routine use of Gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896

    Google Scholar 

  2. Ben-Rafael Z, Lipitz S, Bider D, Mashiach S: Ovarian hyporestrates sponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum durfollicle-stimulating hormone levels. Fertil Steril 1991;55:272–275

    Google Scholar 

  3. Testard J, Lefebvre B, Gougeon A: Effects of Gonadotropin-releasing hormone agonist (GnRHa) on follicle and oocyte quality. Hum Reprod 1993;8:511–518

    Google Scholar 

  4. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343–346

    Google Scholar 

  5. Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman R: A protocol using a low dose of Gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulation hormone concentrations on day 3. Hum Reprod 1996;11:169–1172

    Google Scholar 

  6. Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;6:880–885

    Google Scholar 

  7. Schoolcraft W, Schenker T, Stevens J, Wagley L, Gee M: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93–97

    Google Scholar 

  8. Surrey ES, Brower JA, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419–424

    Google Scholar 

  9. Sandow J, Donnez J: Clinical pharmacokinetics of LHRH analogues. In LHRH Analogues in Gynecology, I Brosens, HS Jacobs, B Runnebaum (eds), Carnforth, UK Pathernon Publishing, 1990, pp 17–31

    Google Scholar 

  10. Broekmans FG, Hompes PGA, Lambalk CB, Shoute E, Broeders A, Schoemaker J: Short term pitutary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin. Hum Reprod 1996;11:55–60

    Google Scholar 

  11. Janssens RMJ, Vermeiden JPW, Lambalk CB, Shats R, Schoemaker J: Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled of ovarian hyperstimulation in IVF. Hum Reprod 1998;13:2386–2391

    Google Scholar 

  12. Cédrin-Durnerin I, Bulwa S, Hervé F, Martin-Pont B, Uzan M, Hugues JN: The hormonal flare-up following gonadotropin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod 1996;11:1859–1863

    Google Scholar 

  13. Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas ATA: Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase. Fertil Steril 1983;39:668–673

    Google Scholar 

  14. Navot D, Rosenwaks Z, Anderson F, Hodgen GD: Gonadotropin-releasing hormone agonist induced ovarian hyperstimulation: Low-dose side effects in women and monkeys. Fertil Steril 1991;55:1069–1075

    Google Scholar 

  15. Deaton JL, Bauguess P, Huffman CS, Miller KA: Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare. J Assist Reprod Genet 1996;13:390–394

    Google Scholar 

  16. Scott RT, Carey KD, Leland M, Navot D: Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons. Fertil Steril 1993;59:1124–1128

    Google Scholar 

  17. Hugues JN, Attalah M, Hervé F, Martin-Pont B, Kottler ML, Santarelli J: Effects of short-term GnRH agonist human menopausal Gonadotropin stimulation in patients pre-treated with progestogen. Hum Reprod 1992;7:1079–1084

    Google Scholar 

  18. Weil SJ, Vendola k, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA: Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations. J Clin Endocrinol Metab 1998;83:2479–2485

    Google Scholar 

  19. Bergh C, Howles CM, Borg K, Hamberger LH, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133–2139

    Google Scholar 

  20. Brzyski RG, Muasher SJ, Froesch K, Simonetti S, Jones GS, Rosenwaks Z: Follicular atresia associated with concurent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitement. Fertil Steril 1988;50:917–921

    Google Scholar 

  21. Loumaye E, Wankrieken L, Depreester S, Psalti I, de Coonan S, Thomas K: Hormonal changes by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyper-stimulation for in vitro fertilization and their consequences for embryonic development. Fertil Steril 1989;51:105–111

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bständig, B., Cédrin-Durnerin, I. & Hugues, J.N. Effectiveness of Low Dose of Gonadotropin Releasing Hormone Agonist on Hormonal Flare-Up. J Assist Reprod Genet 17, 113–117 (2000). https://doi.org/10.1023/A:1009470101732

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009470101732

Navigation